ROCHESTER, NEW YORK — Neuroscience company Cognivue, Inc. has announced the appointment of Jason Agran, MD, PhD, as its chief medical officer and senior vice president, effective February 7, 2022.
Dr. Agran brings a wealth of experience in neurosurgery, neuroimaging, memory study, attention modulation, and emergency medicine to the role. He succeeds Fred Ma, MD, PhD who is retiring.
“We are very excited to welcome Dr. Agran to Cognivue. Leading our clinical and medical affairs team, Jason lends significant expertise for ongoing and future clinical validation studies, programs, projects, and technology. His neuroscience experience is invaluable as we further cognitive assessment technologies, data collection, and training programs in healthcare settings across North America.”
–Cognivue President and CEO Tom O’Neill
Dr. Jason Agran said, “I am very pleased to join the Cognivue team and work to further validate and expand the clinical indications for digital cognitive health assessment. As we continue to refine our clinical analyses of Cognivue Clarity and Thrive data points, we will be in a position to ultimately help even more at-risk patient populations.”
Dr. Agran completed his medical, research, and post-doctoral training at the University of Illinois in Urbana-Champaign, studying memory, attention modulation, and novel neuroimaging techniques at the Beckman Institute for Advanced Science and Technology.
Dr. Agran then entered residency training in neurosurgery, adding a year of clinical fellowship in functional neurosurgery, before being recruited to lead the research and development team at Medtronic Neuro. As the director of global research for the restorative therapies group, he was responsible for all neuromodulation and neuro-targeted drug delivery R&D activities and his department developed and refined novel technologies for the treatment of neurologic dysfunction, degeneration, and pain in cellar, animal, and human pre-clinical studies.
Dr. Agran then shifted his focus to training on the frontlines of emergency medicine, completing a second residency at the University of Florida and serving as chief resident. Dr. Agran is board-certified in emergency medicine and is currently in clinical practice.
He will split his time between his home in Georgia, Cognivue’s headquarters in Rochester, NY, and on the road with partners and customers.
About Cognivue, Inc.
Cognivue, Inc. is a world-class neuroscience company focusing on cognitive health with the world’s first FDA-cleared computerized test of cognitive function. The Cognivue device and technology are based on years of research that uses adaptive psychophysics to focus on cortical information processing by testing key cognitive domains. The technology significantly improves the ability of healthcare providers to implement a personalized assessment of cognitive function in a wide variety of care settings. The company is elevating the gold standard of cognitive health assessment and empowering the healthcare community to monitor, identify and act on early detection of cognitive health concerns.